Nitric oxide-targeted protein phosphorylation during human sperm capacitation.
Florentin-Daniel StaicuJuan Carlos Martínez-SotoSebastian CánovasCarmen MatásPublished in: Scientific reports (2021)
Among many other molecules, nitric oxide insures the correct progress of sperm capacitation by mediating phosphorylation events. For a more comprehensive understanding of how this happens, we capacitated human spermatozoa from healthy men in the presence/absence of S-Nitrosoglutathione, a nitric oxide donor, two nitric oxide synthase inhibitors, NG-Nitro-L-arginine Methyl Ester Hydrochloride and Aminoguanidine Hemisulfate salt and, finally, with/without L-Arginine, the substrate for nitric oxide synthesis, and/or human follicular fluid. When analyzing the phosphorylation of protein kinase A substrates and tyrosine residues, we particularly observed how the inhibition of nitric oxide synthesis affects certain protein bands (~ 110, ~ 87, ~ 75 and ~ 62 kD) by lowering their phosphorylation degree, even when spermatozoa were incubated with L-Arginine and/or follicular fluid. Mass spectrometry analysis identified 29 proteins in these species, related to: spermatogenesis, binding to the zona pellucida, energy and metabolism, stress response, motility and structural organization, signaling and protein turnover. Significant changes in the phosphorylation degree of specific proteins could impair their biological activity and result in severe fertility-related phenotypes. These findings provide a deeper understanding of nitric oxide's role in the capacitation process, and consequently, future studies in infertile patients should determine how nitric oxide mediates phosphorylation events in the species here described.
Keyphrases
- nitric oxide
- nitric oxide synthase
- protein kinase
- endothelial cells
- hydrogen peroxide
- mass spectrometry
- induced pluripotent stem cells
- ejection fraction
- type diabetes
- small molecule
- newly diagnosed
- high resolution
- adipose tissue
- metabolic syndrome
- escherichia coli
- prognostic factors
- cystic fibrosis
- skeletal muscle
- staphylococcus aureus
- drug delivery
- young adults
- current status
- body composition
- polycystic ovary syndrome
- biofilm formation
- patient reported outcomes
- middle aged
- postmenopausal women
- solid phase extraction